美国食品和药物管理局推出人工智能工具Elsa,以简化操作并加快审查流程. FDA introduces AI tool Elsa to streamline operations and speed up review processes.

美国食品和药物管理局推出了一种名为Elsa的新人工智能工具, The FDA has launched a new AI tool called Elsa to boost efficiency in its operations. 通过安全的GovCloud环境运行,Elsa帮助FDA员工访问内部文件,并通过处理重复的任务,如总结不良事件和比较药物标签来加快审查过程. Running in a secure GovCloud environment, Elsa helps FDA employees access internal documents and speeds up the review process by handling repetitive tasks such as summarizing adverse events and comparing drug labels. 该工具已经用于加快临床审查和科学评价,并计划随着Elsa的发展纳入更多的AI功能。 The tool is already being used to expedite clinical reviews and scientific evaluations, with plans to integrate more AI functions as Elsa evolves.